We are pleased to invite you to read the highly cited papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Clinical Research of Cancer”. We hope this announcement will provide useful information for this field.

The papers list is as follows:

“The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer”
by Jerome Canady, Saravana R. K. Murthy, Taisen Zhuang, Steven Gitelis, Aviram Nissan, Lawan Ly, Olivia Z. Jones, Xiaoqian Cheng, Mohammad Adileh, Alan T. Blank et al.
Cancers 2023, 15(14), 3688; https://doi.org/10.3390/cancers15143688
Available online: https://www.mdpi.com/2072-6694/15/14/3688

“Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [⁶⁸Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation”
by Fanny Lundmark, Ayman Abouzayed, Sara S. Rinne, Vasiliy Timofeev, Nadezhda Sipkina, Maria Naan, Anastasia Kirichenko, Maria Vasyutina, Daria Ryzhkova, Vladimir Tolmachev et al.
Cancers 2023, 15(2), 442; https://doi.org/10.3390/cancers15020442
Available online: https://www.mdpi.com/2072-6694/15/2/442

“Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer”
by Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Manon Reda, Juliette Albuisson, Laurent Arnould et al.
Cancers 2023, 15(4), 1299; https://doi.org/10.3390/cancers15041299
Available online: https://www.mdpi.com/2072-6694/15/4/1299

“A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)”
by Joshua D. Rosenblat, Froukje E. deVries, Zoe Doyle, Roger S. McIntyre, Gary Rodin, Camilla Zimmermann, Ernie Mak, Breffni Hannon, Christian Schulz-Quach, Aida Al Kindy et al.
Cancers 2023, 15(2), 400; https://doi.org/10.3390/cancers15020400
Available online: https://www.mdpi.com/2072-6694/15/2/400

“A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma”
by Chijioke Nze, Pavlos Msaouel, Mohamed H. Derbala, Bettzy Stephen, Abdulrahman Abonofal, Funda Meric-Bernstam, Nizar M. Tannir and Aung Naing
Cancers 2023, 15(15), 3806; https://doi.org/10.3390/cancers15153806
Available online: https://www.mdpi.com/2072-6694/15/15/3806

“Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer”
by Yeong Gyu Jeong, Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Sa Deok Hong, Seong Min Park, Seul-Gi Kim, Tae Hoen Kim and Yong Wha Moon
Cancers 2023, 15(19), 4887; https://doi.org/10.3390/cancers15194887
Available online: https://www.mdpi.com/2072-6694/15/19/4887

“Prevalence of Homologous Recombination Deficiency in First-Line PARP Inhibitor Maintenance Clinical Trials and Further Implication of Personalized Treatment in Ovarian Cancer”
by E Sun Paik, Ha Kyun Chang and Sanghoon Lee
Cancers 2023, 15(12), 3095; https://doi.org/10.3390/cancers15123095
Available online: https://www.mdpi.com/2072-6694/15/12/3095

“Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?”
by Michael Tachezy, Florian Gebauer, Emre Yekebas and Jakob Robert Izbicki
Cancers 2023, 15(17), 4262; https://doi.org/10.3390/cancers15174262
Available online: https://www.mdpi.com/2072-6694/15/17/4262

“Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas”
by Angela Buonadonna, Simona Scalone, Davide Lombardi, Arianna Fumagalli, Alessandra Guglielmi, Chiara Lestuzzi, Jerry Polesel, Vincenzo Canzonieri, Stefano Lamon, Petros Giovanis et al.
Cancers 2023, 15(20), 5036; https://doi.org/10.3390/cancers15205036
Available online: https://www.mdpi.com/2072-6694/15/20/5036

“A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia”
by Neil Palmisiano, Grace Jeschke, Lindsay Wilde, Onder Alpdogan, Matthew Carabasi, Joanne Filicko-O’Hara, Dolores Grosso, Thomas Klumpp, Ubaldo Martinez, John Wagner et al.
Cancers 2023, 15(21), 5129; https://doi.org/10.3390/cancers15215129
Available online: https://www.mdpi.com/2072-6694/15/21/5129

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office